Your browser doesn't support javascript.
loading
ESR2 Drives Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer and Tumorigenesis In Vivo.
Piperigkou, Zoi; Koutsandreas, Anastasios; Franchi, Marco; Zolota, Vasiliki; Kletsas, Dimitrios; Passi, Alberto; Karamanos, Nikos K.
Afiliação
  • Piperigkou Z; Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece.
  • Koutsandreas A; Foundation for Research and Technology-Hellas (FORTH)/Institute of Chemical Engineering Sciences (ICE-HT), Patras, Greece.
  • Franchi M; Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece.
  • Zolota V; Department for Life Quality Study, University of Bologna, Rimini, Italy.
  • Kletsas D; Department of Pathology, School of Medicine, University of Patras, Patras, Greece.
  • Passi A; Laboratory of Cell Proliferation and Ageing, Institute of Biology, National Centre for Scientific Research (N.C.S.R). "Demokritos", Athens, Greece.
  • Karamanos NK; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Front Oncol ; 12: 917633, 2022.
Article em En | MEDLINE | ID: mdl-35719919

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article